Delivery Order SPE2DR25D3016-SPE2DR26FG1CB
- Not listed
- The Defense Logistics Agency awarded a $2,208.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 mL, a human growth hormone treatment. The contract, issued on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a competitively awarded procurement with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order valued at $2,095.32 to AmerisourceBergen Drug Corp for Norditropin Flexpro 15 mg/1.5 mL, a human growth hormone medication, with delivery expected by October 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,360.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Norditropin FlexPro 10 mg/1.5 ml pharmaceutical products, with an ultimate completion date of November 10, 2025. This non-set-aside competitive award was issued on November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 ml, a human growth hormone medication, valued at $5,005.52 with a firm fixed price structure. The delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 23, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.84 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed price delivery order, issued on September 19, 2025, with an ultimate completion date of September 22, 2025, represents a routine pharmaceutical procurement under the company's broader relationship with DLA. The contract was competitively awarded with no set-aside designation and will be...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Norditropin FlexPro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order, valued at $2,208.18, is set to be completed by November 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract...
- The Defense Logistics Agency awarded a delivery order valued at $22,018.26 to AmerisourceBergen Drug Corp for Norditropin Flexpro 15 mg/1.5 mL, a human growth hormone medication. This firm fixed-price delivery order, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with DLA. The contract specifies performance at the vendor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,354.52 to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 mL, a human growth hormone medication. The award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, represents a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its corporate office location in the same jurisdiction. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,285.06 for Norditropin FlexPro 5 mg/1.5 mL, a human growth hormone medication. This firm fixed-price, non-set-aside contract was awarded on September 26, 2025, with an ultimate completion date of September 29, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,764.09 to AmerisourceBergen Drug Corp for the supply of Norditropin FlexPro 15 mg/1.5 ml, a human growth hormone medication used to treat growth disorders and related conditions. The award, issued on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG1CBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,425.04 to AmerisourceBergen Drug Corp for Norditropin Flexpro 10 mg/1.5 mL, a human growth hormone medication. The contract was awarded on November 14, 2025, with an ultimate completion date of November 17, 2025, under firm fixed pricing with no set-aside designation. Performance of this delivery order will occur at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The company's DLA prime vendor contract enables flexible delivery of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency requirements and other federal healthcare customers worldwide. This specific delivery order for Norditropin represents one of numerous competitively awarded, firm fixed-price transactions that demonstrate AmerisourceBergen's capability to fulfill federal medical supply needs across varying order values and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 11/14/25 |